KER-047
KER047-IR-202
Phase 2 small_molecule terminated
Quick answer
KER-047 for Iron Deficiency Anemia is a Phase 2 program (small_molecule) at Keros Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Keros Therapeutics
- Indication
- Iron Deficiency Anemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated